Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Bausch + Lomb Corporation has received a consensus recommendation of "Hold" from eleven research firms, with one sell, seven hold, and three buy ratings.
• The company reported a quarterly revenue of $1.28 billion, exceeding analyst estimates, and a 0.07 EPS, beating the consensus estimate by $0.01.
• Recent institutional trading shows significant investments, with Deutsche Bank acquiring a new stake worth approximately $50.75 million in Bausch + Lomb.

Shares of Bausch + Lomb Corporation (NYSE:BLCO - Get Free Report) have earned an average recommendation of "Hold" from the eleven research firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $15.5556.

Several analysts have recently commented on the stock. Barclays lowered their price target on shares of Bausch + Lomb from $19.00 to $16.00 and set an "equal weight" rating on the stock in a research report on Monday, June 9th. Evercore ISI increased their price target on shares of Bausch + Lomb from $15.50 to $16.00 and gave the company an "outperform" rating in a research report on Tuesday, July 8th. Citigroup increased their price target on shares of Bausch + Lomb from $13.00 to $15.00 and gave the company a "neutral" rating in a research report on Wednesday, July 9th. Morgan Stanley raised their target price on shares of Bausch + Lomb from $12.00 to $13.00 and gave the stock an "equal weight" rating in a research report on Friday, August 1st. Finally, Wells Fargo & Company raised their target price on shares of Bausch + Lomb from $12.00 to $15.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 31st.

Bausch + Lomb Stock Up 2.1%

BLCO stock opened at $15.31 on Friday. The company's 50 day simple moving average is $14.30 and its 200-day simple moving average is $13.44. The firm has a market capitalization of $5.42 billion, a PE ratio of -19.63, a P/E/G ratio of 1.53 and a beta of 0.63. Bausch + Lomb has a 12 month low of $10.45 and a 12 month high of $21.69. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.55 and a quick ratio of 0.98.

Bausch + Lomb (NYSE:BLCO - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.06 by $0.01. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.25 billion. Bausch + Lomb had a negative net margin of 5.58% and a positive return on equity of 2.33%. The company's quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.13 earnings per share. Bausch + Lomb has set its FY 2025 guidance at EPS. Equities analysts expect that Bausch + Lomb will post 0.74 earnings per share for the current fiscal year.

Institutional Trading of Bausch + Lomb

A number of hedge funds have recently bought and sold shares of BLCO. Deutsche Bank AG acquired a new stake in Bausch + Lomb during the first quarter worth approximately $50,750,000. Oaktree Capital Management LP purchased a new position in Bausch + Lomb during the second quarter worth approximately $32,801,000. Glenview Capital Management LLC raised its stake in Bausch + Lomb by 210.8% during the second quarter. Glenview Capital Management LLC now owns 1,553,855 shares of the company's stock worth $20,216,000 after purchasing an additional 1,053,855 shares during the period. Allianz Asset Management GmbH raised its stake in Bausch + Lomb by 136.6% during the second quarter. Allianz Asset Management GmbH now owns 769,000 shares of the company's stock worth $10,005,000 after purchasing an additional 444,000 shares during the period. Finally, Goldentree Asset Management LP raised its stake in Bausch + Lomb by 14.9% during the second quarter. Goldentree Asset Management LP now owns 2,583,185 shares of the company's stock worth $33,524,000 after purchasing an additional 334,916 shares during the period. Institutional investors and hedge funds own 11.07% of the company's stock.

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.